Log in to search using one of your social media accounts:

How Discriminatory Immigration Policy Affects The Unborn
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.    -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - February 1, 2017 Category: Consumer Health News Source Type: news

Study: HF Patients Should Get Their Flu Shots (CME/CE)
(MedPage Today) -- Preventing respiratory infection seen as especially helpful in vulnerable population (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - February 1, 2017 Category: Respiratory Medicine Source Type: news

Cohero raises $13.3m for connected inhaler tech
Cohero Health said today that it raised more than $13.3 million, according to regulatory filings, in equity and Series A preferred stock. The company sold nearly all of its total offering amount of $13.6 million before closing the round. Over 50 investors have contributed to the offering, which had its 1st sale in October last year. The company said it plans to use part of the funds for general working capital purposes, including the payment of salaries. Get the full story at our sister site, Drug Delivery Business News. The post Cohero raises $13.3m for connected inhaler tech appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 1, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Patient Monitoring Pharmaceuticals Respiratory Wall Street Beat Cohero Health Source Type: news

Dying at home or in hospital dependent on wealth, location and number of diseases
Where people die is often important to them and their families, as well as being important for planning health care services. Most people want to die at home, but most die in hospital.While the trends have been studied in cancer, other diseases, such as respiratory, are rarely looked at even though they are common and... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - February 1, 2017 Category: American Health Source Type: news

Report of the Exploratory Meeting of Emerging Diseases Clinical Assessment and Response Network (EDCARN) Venice, 3-4 December 2015
World Health Organization. 04/04/2016 This 17-page report summarizes an exploratory meeting that was designed to strengthen the Emerging Diseases Clinical Assessment and Response Network (EDCARN) by assembling stakeholders engaged in clinical care and research on emerging infectious diseases, especially during epidemics. Participants discussed topics that included Ebola virus disease, severe acute respiratory syndrome (SARS) coronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), and clinical training for emerging and infectious diseases. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 1, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Hands On Product Reviews February 2017
Electric-Powered Response Providing EMS coverage for large venues is a challenge. Where do you set up an aid station? Where do you stage personnel, ambulances and support vehicles? And often most importantly, how do you move around during the event once the crowd is in place and vehicle traffic is virtually impossible? The new Defender from Trikke is a lightweight, sturdy, transportable option that keeps your head above the crowd. Already popular in law enforcement, the 350-lb. payload of the Defender can carry an EMS provider as well as gear. The 48-volt lithium-ion battery provides enough charge for a range up to 28 mile...
Source: JEMS Operations - February 1, 2017 Category: Emergency Medicine Authors: Fran Hildwine, BS, NREMT-P Tags: Columns Equipment & Gear Source Type: news

Case 2: Respiratory Distress and Chronic Aspiration
(Source: NeoReviews recent issues)
Source: NeoReviews recent issues - January 31, 2017 Category: Pediatrics Authors: Seske, L. M., Prosser, J. D., Haberman, B. E. Tags: Pediatric Drug Labeling Update Index of Suspicion in the Nursery Source Type: news

MicroGuide is more than just antimicrobials
Microguide is a smartphone APP that was first developed to allow clinicians to access up to date pharmacological guidelines from their hospital pharmacy on antimicrobial medications at point of care in clinic. This APP has now been expanded to include access to several other types of clinical guidelines including pain managment, wound formulary, emergency care, diabetes and much more - 50 different types.Tuesday, January 31, 2017 - 16:48Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 31, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Sugar Is Not the New Tobacco, Despite What Some Say Sugar Is Not the New Tobacco, Despite What Some Say
The problem behind obesity is excess calories, not just sugar, and excess calorie consumption is stimulated by excess sweetness, Dr Mike Lean says.Medscape Public Health (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - January 31, 2017 Category: Respiratory Medicine Tags: Public Health & Prevention Commentary Source Type: news

Mylan hit with antitrust lawsuit over EpiPen device
Mylan (NSDQ:MYL) said on Monday that it is undergoing an antitrust probe by the Federal Trade Commission into the company’s commercial practices regarding its EpiPen device. The Canonsburg, Pa.-based company reportedly responded to the allegations that it improperly fought off competition, saying “any suggestion that Mylan took any inappropriate or unlawful actions to prevent generic competition is without merit.” Get the full story at our sister site, Drug Delivery Business News. The post Mylan hit with antitrust lawsuit over EpiPen device appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 31, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Legal News Pharmaceuticals Respiratory Wall Street Beat Mylan Source Type: news

Newton International Fellowships
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 31, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

New Research Shows Breast Cancer Precursor Treatment Causes Women to Live Longer
This study is particularly important because DCIS treatment includes radiotherapy, which can cause damage to nearby organs More and more people are becoming aware they have DCIS because it is something that shows up in breast cancer screenings—so more women are able to get treated if they have this form of cancer. For more information on the study, please visit “Women treated for precursor of breast cancer can expect to live as long as other women.” Follow NN/LM SCR on Twitter and like us on Facebook. (Source: Network News)
Source: Network News - January 31, 2017 Category: Databases & Libraries Authors: NN/LM South Central Region Tags: Consumer Health General (all entries) Patient Safety Public Health Research Source Type: news

Smoking Costs World $1.4 Trillion a Year in Disease, Lost Productivity
Title: Smoking Costs World $1.4 Trillion a Year in Disease, Lost ProductivityCategory: Health NewsCreated: 1/31/2017 12:00:00 AMLast Editorial Review: 1/31/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 31, 2017 Category: Respiratory Medicine Source Type: news

Dying at home or in hospital dependent on wealth, location and number of diseases
(King's College London) In a new study, published today in BMC Medicine, researchers from King's College London's Cicely Saunders Institute studied a national data set of all deaths from two common groups of respiratory diseases -- chronic obstructive pulmonary disease and interstitial pulmonary diseases, covering 380,232 people over 14 years. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 31, 2017 Category: Global & Universal Source Type: news

A new focus on falls prevention
Preventing falls is important for the health and wellbeing of older people as well as the future of our health and social care services, says Kevin Fenton Related items fromOnMedica Elderly failed by broken care system Virtual reality treadmill training could help prevent falls Brain activity may predict falls risk in older adults Vitamin D reduces respiratory infections but may increase falls for older adults Help to prevent falls in hospital (Source: OnMedica Views)
Source: OnMedica Views - January 30, 2017 Category: Primary Care Source Type: news

Pulmatrix seeks to raise $5m in direct offering
Pulmatrix (NSDQ:PULM) said today that it landed an agreement with several institutional investors to purchase $5.0 million of shares of common stock in a registered direct offering. The Lexington, Mass.-based company agreed to sell 2 million shares of common stock at $2.50 apiece. The offering is expected to close on Feb. 2. Pulmatrix said it anticipates that the offering will bring in $4.5 million in net proceeds, which it plans to use for general corporate purposes and debt payments. Get the full story at our sister site, Drug Delivery Business News. The post Pulmatrix seeks to raise $5m in direct offering appeared ...
Source: Mass Device - January 30, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Respiratory Pulmatrix Inc. Source Type: news

Teva wins FDA nod for inhaled asthma medications
Teva Pharmaceuticals (NYSE:TEVA) said today that the FDA approved 2 inhaled asthma medications to be delivered using the company’s RespiClick breath-activated, multi-dose dry powder inhaler. The products, AirDuo RespiClick and ArmonAir RespiClick, are indicated for use in asthma patients as young as 12 years old. The Jerusalem-based company’s AirDuo RespiClick is a fixed dose combination of a corticosteroid and a long-acting beta-adrenergic agonist, while the ArmonAir RespiClick is an inhaled corticosteroid. Get the full story at our sister site, Drug Delivery Business News. The post Teva wins FDA nod...
Source: Mass Device - January 30, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Regulatory/Clearance Respiratory Wall Street Beat Teva Pharmaceuticals Source Type: news

Firefighters with Mesothelioma Protected by New Ohio Law
A new piece of legislation extends workers’ compensation rights for Ohio firefighters to include occupational cancers such as mesothelioma. Ohio Gov. John Kasich signed the Michael Louis Palumbo Jr. Act into law Jan. 4. The bill essentially classifies cancer as an occupational disease for firefighters, allowing firefighters who have cancer to file claims with the Ohio Bureau of Workers’ Compensation. More than 30 states already have similar laws. Doug Stern of the Ohio Association of Professional Firefighters (OAPFF) said the legislation is based on scientific research that links asbestos-related cancers, suc...
Source: Asbestos and Mesothelioma News - January 30, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: firefighters asbestos exposure firefighters with mesothelioma governor john kasich occupational mesothelioma cancer ohio law protects firefighters Source Type: news

Breathlessness could be chronic lung disease: Don’t ignore THESE symptoms
LUNG DISEASE and respiratory conditions account for one in five deaths in the UK - but experts have warned hundreds could be suffering without really realising. (Source: Daily Express - Health)
Source: Daily Express - Health - January 30, 2017 Category: Consumer Health News Source Type: news

List of Pathogens
World Health Organization. 01/26/2017 This Web page provides a List of Priority Diseases 2017, which include Ebola, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Zika virus. It also provides a list of diseases to be urgently addressed under the World Health Organization R&D Blueprint, as of May 2016, and serious diseases necessitating further action as soon as possible, as of May 2016. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 28, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

WHO (World Health Organization) Vaccine Pipeline Tracker
World Health Organization. 04/13/2016 This spreadsheet tracks the vaccine pipeline for HIV, Malaria, TB, Enterics, RSV (Respiratory Syncytial Virus), Ebola, Zika, Dengue, and Priority Emerging Pathogens. Topics in the spreadsheet include Candidate Vaccine Name, Developer/Collaborators, Disease/Pathogen, Indication Goal, Platform, Immunogen, Adjuvant, Most Advanced Trial Phase, Trial Sponsor, and Start Date. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 28, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Climate change and collective violence - Levy BS, Sidel VW, Patz JA.
Climate change is causing increases in temperature, changes in precipitation and extreme weather events, sea-level rise, and other environmental impacts. It is also causing or contributing to heat-related disorders, respiratory and allergic disorders, infe... (Source: SafetyLit)
Source: SafetyLit - January 28, 2017 Category: Global & Universal Tags: Environmental Issues, Climate, Geophysics Source Type: news

The Modern Diagnostic Approach to CAP in Adults The Modern Diagnostic Approach to CAP in Adults
Read about the diagnostic approaches to the adult with suspected community-acquired pneumonia, and find out about emerging technologies that may lead to better identification.Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Oral devices reduce sleep apnea but may not affect heart disease risk factors
(American Thoracic Society) In patients with severe obstructive sleep apnea (OSA), oral appliances that treat the condition by moving the lower jaw forward appear to improve sleep but not reduce key risk factors for developing heart and other cardiovascular disease, according to new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 27, 2017 Category: Global & Universal Source Type: news

This Is When You're Most Likely To Catch The Flu
If you’re wondering when you might get the flu, a new study indicates you should keep an eye on your local weather report. According to research published in the Journal of Clinical Virology, a season’s first cold snap below 37 degrees Fahrenheit (or zero degrees Celsius, as defined in the study) preceded a mass spread of the flu in Gothenberg, a large metropolitan area of Sweden. The researchers suggest that if you keep your eye on the weather and watch for the first major dip in the temperature, you can essentially mark your calendar in anticipation for an influx of the illness.  “We believe that t...
Source: Healthy Living - The Huffington Post - January 26, 2017 Category: Consumer Health News Source Type: news

Johnson & Johnson to pay $30B for Actelion
After weeks of exclusive negotiations, Johnson & Johnson (NYSE:JNJ) said on Thursday that it plans to buy Swiss biotech firm Actelion (VTX:ATLN) for $30 billion in an all-cash deal. The companies have reportedly been in talks for months – Sanofi (NYSE:SNY) was also involved in discussions for Actelion, but was sidelined after J&J entered into exclusive negotiations with Actelion last month. The companies plan to spin off Actelion’s research and development pipeline into a new company, led by Actelion CEO Jean-Paul Clozel. Get the full story at our sister site, Drug Delivery...
Source: Mass Device - January 26, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Mergers & Acquisitions Pharmaceuticals Respiratory Wall Street Beat Actelion Johnson & Johnson Sanofi-Aventis Source Type: news

Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia
Between 2 and 7 January 2017 the National IHR Focal Point of Saudi Arabia reported nine (9) additional cases of Middle East Respiratory Syndrome (MERS) including two (2) fatal cases. Two (2) deaths among previously reported MERS cases (cases no. 7 and 8 in DON published on 17 January 2017) were also reported. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - January 26, 2017 Category: Infectious Diseases Tags: news Source Type: news

1 in 4 U.S. Adults, 1 in 10 Teens Use Tobacco
Title: 1 in 4 U.S. Adults, 1 in 10 Teens Use TobaccoCategory: Health NewsCreated: 1/25/2017 12:00:00 AMLast Editorial Review: 1/26/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 26, 2017 Category: Respiratory Medicine Source Type: news

ResMed's revenue increased 17 percent in fiscal year Q2 2017
San Diego, California-based ResMed, maker of connected respiratory devices, announced strong results for its quarter ending on December 31, with over $530 million in revenue representing a 17 percent increase year over year. (Source: mobihealthnews)
Source: mobihealthnews - January 25, 2017 Category: Information Technology Source Type: news

Narcan (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration
January 25, 2017 – Dublin, Ireland – Today, the U.S. Food and Drug Administration (FDA) approved Narcan Nasal Spray as a 2mg formulation for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 25, 2017 Category: Drugs & Pharmacology Source Type: news

The gift of grandmothers
Nancy and Susan with Sophie at Boston Children’s Hospital’s Neonatal Intensive Care Unit (NICU) Nancy sits in a tiny hospital room in New York City, reading to Sophie, her infant granddaughter who is quarantined while she battles a respiratory virus. She keeps vigil over Sophie so her daughter, Katie, can safely spend time with Sophie’s twin sister, Maddie, and her son-in-law can work to support the family. “There was no one to talk to and nothing to do,” remembers Nancy, “So for days, I just sat with Sophie and read her the A.A. Milne poems my mother used to read to me.” N...
Source: Thrive, Children's Hospital Boston - January 25, 2017 Category: Pediatrics Authors: Jenny Fernandez Tags: Our Patients’ Stories Parenting neonatal intensive care unit Source Type: news

Roche taps Vivonoetics, Great Lakes NeuroTech for wearable respiratory assessment device
Roche (PINK:RHHBY) tapped Vivonoetics and Great Lakes NeuroTechnologies, to provide a wearable respiratory testing device to Roche’s Firefish study. The company’s study aims to evaluate drug efficacy compared to respiratory muscle function and breathing patterns in infants treated for spinal muscular atrophy. Devices traditionally used to measure breathing include masks and mouthpieces, which aren’t always practical for monitoring infants. The Firefish study is the 1st large spinal muscular atrophy clinical trial to use a respiratory inductance plethysmography system to non-invasi...
Source: Mass Device - January 25, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: mHealth (Mobile Health) Pediatrics Respiratory Spinal Wall Street Beat Great Lakes NeuroTechnologies Roche Vivonoetics Source Type: news

Vectura wins IND for drug-device combo for pediatric asthma
Vectura said yesterday that the FDA approved an Investigational New Device application for its drug-device combination to treat asthma in children 12 months to 8 years old. The UK-based company’s device, VR647, uses the Akita Jet nebulizer for the delivery of nebulized budesonide. Vectura’s drug-device combination product provides faster delivery time and better lung deposition of budesonide, according to the company, and enables a patient to potentially lower their dosage while maintaining efficacy. Get the full story at our sister site, Drug Delivery Business News. The post Vectura wins IND for...
Source: Mass Device - January 25, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Food & Drug Administration (FDA) Respiratory Vectura Source Type: news

CEO Becomes an Aspergillosis Survivor
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 25, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Morning Break: Hep C Drug Risks? Drug Resistant Fungus; Dutch'Trump' Trump
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - January 25, 2017 Category: Respiratory Medicine Source Type: news

$80M Asbestos Settlement Reached in Kansas City
An $80 million asbestos settlement involving two former Jackson County courthouse employees led to Missouri’s largest medical monitoring fund established in an asbestos case. The class-action asbestos lawsuit settled more than 30 years after a renovation exposed thousands of government workers to deadly asbestos fibers. Jackson County and Kansas City-based U.S. Engineering, the firm responsible for the asbestos removal, agreed to settle the case in October 2016, just a week prior to the opening trial date. An estimated 7,500 people — former courthouse employees, jurors, attorneys and jail inmates — could...
Source: Asbestos and Mesothelioma News - January 25, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos in kansas city courthouse asbestos lawsuit asbestos litigation in missouri asbestos settlement kansas city asbestos lawsuit kansas city asbestos settlement mesothelioma lawsuit mesothelioma lawyer in missouri Source Type: news

Meet Anne Schuchat, The Pro-Vaccine Researcher Who Just Took Over The CDC
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.  function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments....
Source: Healthy Living - The Huffington Post - January 24, 2017 Category: Consumer Health News Source Type: news

Why These Preemie Parents Are Sharing Their NICU Photos
On Sep. 23, 2015, Jourdan and Matt Moore welcomed their twin son and daughter, Jaxson and Cadence. The babies were born four months early and went on to spend over three months in the NICU. The experience was difficult for the Moores to say the least, but now the twins are healthy and thriving at home. Jourdan and Matt are sharing photos from the NICU, along with images of their progress, to offer a message of hope to other parents in that difficult situation. On this day... One year ago October 16th Jaxson fit inside his daddy's hand. He was 23 days old and weighed 1lb 8oz. Exactly one week prior he had a breat...
Source: Healthy Living - The Huffington Post - January 24, 2017 Category: Consumer Health News Source Type: news

Why These Preemie Parents Are Sharing Their NICU Photos
On Sep. 23, 2015, Jourdan and Matt Moore welcomed their twin son and daughter, Jaxson and Cadence. The babies were born four months early and went on to spend over three months in the NICU. The experience was difficult for the Moores to say the least, but now the twins are healthy and thriving at home. Jourdan and Matt are sharing photos from the NICU, along with images of their progress, to offer a message of hope to other parents in that difficult situation. On this day... One year ago October 16th Jaxson fit inside his daddy's hand. He was 23 days old and weighed 1lb 8oz. Exactly one week prior he had a breat...
Source: Science - The Huffington Post - January 24, 2017 Category: Science Source Type: news

Diagnosis and Therapy of Fungal Diseases
Date: Tuesday, January 24, 2017Year: 2017Location: Belgrade, SerbiaContent-type: current_conferences (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Asthma Can Be More Serious for African-Americans; New Research Suggests Why
Untitled by InspiredImages is licensed under CC0. Asthma, a chronic respiratory condition in which a person’s airways are always inflamed that can make it difficult to breathe, can be a much more serious condition for people who are black than those that are white. In fact, people who are black are 2 to 3 times more likely to be hospitalized for asthma than people who are white. New research is suggesting that the difference in airway inflammation affects a patient’s response to treatment. It was just recently that scientists discovered that airway inflammations vary among different races. Researchers analyzed...
Source: Network News - January 24, 2017 Category: Databases & Libraries Authors: Brian Leaf Tags: General (all entries) Source Type: news

ResMed shares lift on Street-beating Q2
Shares in ResMed (NYSE:RMD) have risen in premarket trading today after the respiratory-focused device maker topped expectations on Wall Street with its 2nd quarter results. The San Diego, Calif.-based company posted profits of $76.7 million, or 54¢ per share, on sales of $530.4 million for the 3 months ended December 31. That amounts to a bottom-line slide of 19.7% while sales grew 16.7% compared with the same period in 2015. After adjusting to exclude 1-time items, earnings per share were at 73¢, ahead of the 70¢ consensus on The Street, where analysts were looking for sales of $514.7 million. &l...
Source: Mass Device - January 24, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Wall Street Beat ResMed Inc. Source Type: news

Medical Abbreviations (Acronyms and Definitions)
Title: Medical Abbreviations (Acronyms and Definitions)Category: Diseases and ConditionsCreated: 1/24/2017 12:00:00 AMLast Editorial Review: 1/24/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 24, 2017 Category: Respiratory Medicine Source Type: news

Health Tip: Stop Smoking!
Title: Health Tip: Stop Smoking!Category: Health NewsCreated: 1/24/2017 12:00:00 AMLast Editorial Review: 1/24/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 24, 2017 Category: Respiratory Medicine Source Type: news

Help to prevent falls in hospital
New tool makes for speedy assessment of potential vision problems Related items fromOnMedica Virtual reality treadmill training could help prevent falls Brain activity may predict falls risk in older adults Vitamin D reduces respiratory infections but may increase falls for older adults Hospitals must adapt to better support dementia patients Elderly failed by broken care system (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 23, 2017 Category: UK Health Source Type: news

J & J, Actelion still in talks despite Opsumit failure
Although Actelion (VTX:ATLN)’s Opsumit drug candidate missed its primary endpoint in a phase III trial for patients suffering from a deadly heart-lung condition, analysts reportedly concluded that the result is unlikely to have an impact on merger talks with Johnson & Johnson (NYSE:JNJ). The Swiss drugmaker’s trial involved 226 patients with Eisenmenger Syndrome, which causes untreated congenital heart defects and pulmonary hypertension. Get the full story at our sister site, Drug Delivery Business News. The post J&J, Actelion still in talks despite Opsumit failure appeared first on ...
Source: Mass Device - January 23, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Mergers & Acquisitions Respiratory Wall Street Beat Actelion Pharmaceuticals Johnson & Johnson Source Type: news

ResMed buries the hatchet with China ’ s BMC Medical
ResMed (NYSE:RMD) and China’s BMC Medical agreed to bury the hatchet, saying last week that their agreement puts to bed all of the long-simmering litigation between the sleep apnea device makers. The patent infringement disputes date back at least to June 2013, when ResMed filed a lawsuit against BMC and its U.S. distributor, 3B Medical. That case involved patents covering continuous positive airway pressure devices, a nasal mask and a nasal pillow interface. Both sides claimed wins the following year when the International Trade Commission issued a mixed ruling, finding t...
Source: Mass Device - January 23, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Legal News Patent Infringement Respiratory 3B Medical BMC Medical ResMed Inc. Source Type: news

Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties.
Echinocandins are first-line therapy for candidemia and invasive candidiasis. They are generally safe with few drug interactions, but the stability and pharmacokinetic properties of currently approved echinocandins are such that each was developed for daily intravenous infusion. We sought to discover a novel echinocandin with properties that would enable more flexible dosing regimens, alternate routes of delivery, and expanded utility. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 23, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.
CD101 IV is a novel echinocandin with distinctive pharmacokinetic properties that is being developed as a once-weekly treatment for candidemia and invasive candidiasis. CD101 has potent in vitro activity and in vivo efficacy against a broad range of Candida and Aspergillus species. The primary objective of two randomized, double-blind, placebo-controlled, dose-escalation studies in healthy adults was to determine the safety and tolerability of CD101 IV. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 23, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

What is in the Differential Diagnosis of Fatigue?
Discussion Fatigue is a subjective feeling of decreased energy, tiredness or feeling of exhaustion. Lethargy is often used synonymously, but lethargy is a state of being drowsiness or sleepy, and implies mental status changes. Both can cause the person to be apathetic or less active. Fatigue is a common state that almost everyone experiences multiple times in his or her lifetime. For most people it is a relatively acute or short-term chronic problem, often with a relatively easily identifiable problem cause, such as inadequate sleep, acute illness, or overexertion. For some, it can be less readily identifiable such as dep...
Source: PediatricEducation.org - January 23, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news